[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:immunodeficiency-related-large-b-cell-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Immunodeficiency-Related Large B-Cell Lymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT06723457","Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma",[11],"Phase 2","RECRUITING","2026-08-26T02:17:54.420226Z","2026-07-19T19:36:05.137870Z",[],[]]